iHEA

International Health Economics Association

8th World Congress: Transforming Health and Economics

Advertisement: 8th World Congress: Transforming Health and Economics

« 18th annual RAND Summer Institute (RSI) | Main | Call for Papers: 10th Journees Louis-Andre Gerard-Varet Conference in Public Economics »

March 14, 2011

Pharmaceutical and Medical Device Market Access in Germany after Major Pricing and Reimbursement Reform Understanding the regulatory impact and demonstrating value to today's new stakeholders in Europe's most significant market

Location: Berlin, Germany
Conference Dates: March 14-15th, 2011

Unlike other general market access meetings, this event will purely focus on the large and globally significant German market and healthcare system, about to undertake immense change. The focused topics and presented by thought-leaders, will guarantee that all participants are exposed to beneficial information and experiences which can increase their chances to achieve market and patient access goals in a dynamic, mature pharmaceutical marketplace, central to global pricing strategy.

Why Attend?

  • Focus on the unique and largest European market, that is central to global pricing strategy.
  • Evaluate how pricing and reimbursement will be affected under the imminent AMNOG pricing and reimbursement reforms.
  • Hear policy makers’ and payers’ views, initiatives and incentives on how the system will work in practice.
  • Learn how innovation will be measured and rewarded in Germany from 2011 onwards.
  • Understand all stakeholders’ roles in the decision making process in the new healthcare reform.
  • Find out more about the implementation of new contracting options in Germany and their affect on pricing, market access and competition.
  • Learn how to overcome pricing challenges and market access delays in niche markets.
  • Network with key decision makers who are the first to implement this significant reform.

Who will benefit

  • Pharmaceutical and Medical devices companies:
  • Global, European and German Vice-Presidents, Directors, Managers involved in:
  • Pricing and Reimbursement, Health Economics and Outcomes, Government and Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Market Access, Country Managers
  • Solution providers and consultants:
  • CEOs, Business Development, Senior Consultants, Regional Heads Independent Academics, Health Economists, Government Officials, Public and Private Healthcare Providers, Senior Doctors, and Patient Representatives.

Agenda request

To request the full agenda please click here

For Booking Information contact:

Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: http://www.nextlevelpharma.com

permalink March 2011: Pharmaceuticals

Contact

iHEA 902-461-4432
902-461-IHEA
416-352-1395 fax

Tom GetzenExecutive Director and CEO
215-242-1196

Bill SwanDeputy CEO